RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives.
RedHill applies innovation, focus and a collective mindset of delivering on our promises in building a company primarily focused on U.S commercialization and development of drugs for gastrointestinal, infectious and oncologic diseases.
We have built an R&D pipeline of proprietary mid-to-late-stage clinical development drug candidates addressing major unmet medical needs.